Jane Street’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.9M | Sell |
5,500
-4,100
| -43% | -$2.3M | ﹤0.01% | 4571 |
|
|
2026
Q1 | $5.39M | Sell |
9,600
-23,200
| -71% | -$14.9M | ﹤0.01% | 3396 |
|
|
2025
Q4 | $22.2M | Buy |
32,800
+23,200
| +242% | +$15.8M | ﹤0.01% | 1530 |
|
|
2025
Q3 | $6.13M | Buy |
9,600
+1,400
| +17% | +$850K | ﹤0.01% | 3116 |
|
|
2025
Q2 | $4.4M | Sell |
8,200
-17,400
| -68% | -$8.32M | ﹤0.01% | 3175 |
|
|
2025
Q1 | $10.8M | Sell |
25,600
-13,300
| -34% | -$5.78M | ﹤0.01% | 1903 |
|
|
2024
Q4 | $16.1M | Sell |
38,900
-1,800
| -4% | -$790K | ﹤0.01% | 1451 |
|
|
2024
Q3 | $20.6M | Buy |
40,700
+36,400
| +847% | +$17.7M | ﹤0.01% | 1218 |
|
|
2024
Q2 | $2.09M | Buy |
4,300
+1,800
| +72% | +$904K | ﹤0.01% | 4391 |
|
|
2024
Q1 | $1.35M | Sell |
2,500
-3,000
| -55% | -$1.64M | ﹤0.01% | 4843 |
|
|
2023
Q4 | $3.05M | Buy |
5,500
+1,700
| +45% | +$798K | ﹤0.01% | 3603 |
|
|
2023
Q3 | $1.66M | Sell |
3,800
-32,500
| -90% | -$16.2M | ﹤0.01% | 4349 |
|
|
2023
Q2 | $18.2M | Sell |
36,300
-14,200
| -28% | -$6.8M | 0.01% | 1305 |
|
|
2023
Q1 | $25.3M | Buy |
50,500
+1,700
| +3% | +$814K | 0.01% | 852 |
|
|
2022
Q4 | $19.9M | Buy |
48,800
+39,100
| +403% | +$15.2M | 0.01% | 1013 |
|
|
2022
Q3 | $3.16M | Sell |
9,700
-32,100
| -77% | -$11.8M | ﹤0.01% | 3357 |
|
|
2022
Q2 | $14.7M | Buy |
41,800
+19,500
| +87% | +$7.95M | 0.01% | 1374 |
|
|
2022
Q1 | $12.2M | Sell |
22,300
-42,000
| -65% | -$22.1M | ﹤0.01% | 1742 |
|
|
2021
Q4 | $42.3M | Sell |
64,300
-8,400
| -12% | -$5.27M | 0.01% | 724 |
|
|
2021
Q3 | $45.2M | Buy |
72,700
+46,300
| +175% | +$31.1M | 0.02% | 644 |
|
|
2021
Q2 | $16.7M | Buy |
26,400
+2,700
| +11% | +$1.49M | 0.01% | 1233 |
|
|
2021
Q1 | $11.6M | Sell |
23,700
-13,000
| -35% | -$6.51M | 0.01% | 1417 |
|
|
2020
Q4 | $18.3M | Buy |
36,700
+33,000
| +892% | +$14.8M | 0.01% | 927 |
|
|
2020
Q3 | $1.46M | Sell |
3,700
-18,800
| -84% | -$6.95M | ﹤0.01% | 3507 |
|
|
2020
Q2 | $7.43M | Buy |
22,500
+14,900
| +196% | +$4.31M | 0.01% | 1424 |
|
|
2020
Q1 | $1.84M | Sell |
7,600
-28,300
| -79% | -$7.39M | ﹤0.01% | 2103 |
|
|
2019
Q4 | $9.38M | Buy |
35,900
+33,500
| +1,396% | +$8.83M | 0.01% | 675 |
|
|
2019
Q3 | $653K | Buy |
+2,400
| New | +$668K | ﹤0.01% | 3176 |
|
|
2018
Q1 | – | Sell |
-2,900
| Closed | -$454K | – | 5063 |
|
|
2017
Q4 | $454K | Buy |
+2,900
| New | +$456K | ﹤0.01% | 3292 |
|
Other funds holding IDXX
Jane Street's IDXX Position: Q2 2026 in Review
Jane Street increased its Idexx Laboratories (IDXX) stake by 601% in Q2 2026, buying an estimated $50.5M and bringing the position to 105,108 shares worth $55.3M. The position accounts for ﹤0.01% of the portfolio, ranked #1341.
Jane Street first reported a position in IDXX in Q2 2013 and has held it in 46 quarters since. 1,305 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Jane Street held 105,108 shares of Idexx Laboratories worth $55.3M as of Q2 2026.
- Jane Street bought 90,110 Idexx Laboratories shares in Q2 2026, an estimated $50.5M.
- Idexx Laboratories made up ﹤0.01% of Jane Street's portfolio in Q2 2026, its #1341 holding.
- Jane Street first reported a position in Idexx Laboratories in Q2 2013 and has held it in 46 quarters since.
- 1,305 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Jane Street's 13F filing for Q2 2026, filed 14 Aug 2026.